Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 21Recruiting 10Completed 4Terminated 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 1

Interventions

Specimen Handling 30Magnetic Resonance Spectroscopy 21Biopsy 21Cyclophosphamide 8venetoclax 5Taxes 5Bevacizumab 5X-Rays 4Vincristine 4Surgical Procedures, Operative 4Nivolumab 4Etoposide 4Cetuximab 4Azacitidine 4fludarabine phosphate 3fludarabine 3decitabine and cedazuridine drug combination 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Radiation 3Prednisone 3Immunoglobulin G 3Gemcitabine 3Doxorubicin 3Disulfides 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3zanubrutinib 2trastuzumab deruxtecan 2prednylidene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × trametinib × 90 days × Clear all
NCT04485559 2026-04-13

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

University of California, San Francisco

Phase 1 Suspended
50 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡